We provide independent financial valuation for event driven and M&A investors. Our work stays close to what matters when a deal is live. We look at stand alone worth, the economics of a proposed merger, and how value is likely to move as facts change. In most public deals the acquisition premium is the single biggest factor in whether a transaction succeeds, and we specialise in rigorous valuation to judge whether an offer is fair for both the target and the acquirer.
Price is only part of the story in public M&A. We test the stand-alone case for the target, the re-rate risk for the acquirer, and the value created or lost through synergies, financing choices and deal structure.
Our work is anchored in filings and audited numbers, and then we ask what is truly recurring, what should be normalised, and how sector cycles, regulation and capital allocation shape the range of outcomes. When the analysis supports a higher or lower price, we explain why and tie that view to the specific milestones that are likely to move the market, such as regulatory steps, shareholder votes and financing events.
We start with the documents and the numbers, reading the merger agreement, proxy and other filings, then building live models for both the target and the acquirer that stay lean firmly on disclosures. Our valuation toolkit includes discounted cash flow, leveraged buyout, comparable companies, precedent transactions and sum of the parts, and we also run accretion and dilution, return on invested capital and pro forma leverage so you can see how each term in the agreement shows up in value.
To frame risk and reward, we estimate break price ranges using a straightforward proprietary method that blends correlation work with valuation multiples, and we map scenarios with explicit probabilities so close, delay, recut or break are shown in clear numbers. We handle the accounting detail by adjusting for leases, stock based pay, restructuring and other items that are not recurring, and we reconcile US GAAP and IFRS where they differ. The result is a simple, readable research that you can challenge line by line. We work globally across sectors, and we are completely independent: we do not trade, broker or accept issuer fees.
If you are a qualified investor and would like to speak to us about a live valuation question, please get in touch.